The Journal of Organic Chemistry
Note
7.54 (dd, J = 8.2 Hz, J = 6.7 Hz, 2H), 7.47−7.37 (m, 1H), 7.30 (ddd,
J = 7.7 Hz, J = 3.1 Hz, J = 1.9 Hz, 2H), 7.20 (dt, J = 4.9 Hz, J = 3.2
Hz, 1H), 4.53 (s, 2H), 4.52 (s, 2H); 13C{1H} NMR (75 MHz,
CDCl3) δ 197.2, 136.6, 136.4, 134.1, 133.5, 131.4, 130.7, 129.2, 128.8,
128.5, 127.8, 42.5, 32.5; HRMS (ESI) m/z [M + H]+ calcd for
C15H14BrO 289.0222, found 289.0212.
A 1 mmol scale of reaction was conducted by the same procedure
with 1a (210.1 mg, 1.0 mmol), TMSBr (160 μL, 184.9 mg, 1.2
mmol), and CH2Cl2 (20 mL) to yield 2a (202.5 mg, 0.71 mmol,
71%). Compound 2a was also prepared from 3a (10.0 mg, 0.05
mmol) and TMSBr (7.7 μL, 8.8 mg, 0.06 mmol) in CH2Cl2 (1 mL).
After being stirred at rt for 72 h, the reaction mixture was
concentrated, and product 2a (13.1 mg, 0.04 mmol, 92%) was
isolated after column chromatography.
134.3, 131.4, 130.7, 129.2, 129.0, 128.7, 127.8, 126.7, 125.7, 42.5,
32.5, 21.4; HRMS (ESI) m/z [M + H]+ calcd for C16H16BrO
303.0379, found 303.0374.
2-(2-(Bromomethyl)phenyl)-1-(p-tolyl)ethanone (2g). The gen-
eral procedure was followed. Starting with 1g (50.0 mg, 0.23 mmol)
and TMSBr (37 μL, 42.8 mg, 0.28 mmol) in CH2Cl2 (5 mL), 2g
(67.5 mg, 0.22 mmol, 97%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light
yellow oil: 1H NMR (300 MHz, CDCl3) δ 8.04−7.95 (m, 2H), 7.46−
7.37 (m, 1H), 7.37−7.25 (m, 4H), 7.20−7.17 (m, 1H), 4.52 (s, 2H),
4.51 (s, 2H), 2.46 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 196.8,
144.4, 136.4, 134.4, 134.2, 131.4, 130.6, 129.5, 129.2, 128.6, 127.7,
42.3, 32.6, 21.7; HRMS (ESI) m/z [M + H]+ calcd for C16H16BrO
303.0379, found 303.0372.
2-(2-(Bromomethyl)phenyl)-1-(2-methoxyphenyl)ethanone (2b).
The general procedure was followed. Starting with 1b (50.0 mg, 0.21
mmol), TMSBr (33 μL, 37.9 mg, 0.25 mmol) in CH2Cl2 (5 mL), 2b
(58.6 mg, 0.18 mmol, 88%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light
yellow oil: 1H NMR (300 MHz, CDCl3) δ 7.62−7.47 (m, 1H), 7.38−
7.31 (m, 1H), 7.35−7.17 (m, 1H), 7.23−7.03 (m, 2H), 7.08−6.97
(m, 1H), 6.95−6.74 (m, 2H), 4.56 (s, 2H), 4.55 (s, 2H), 4.00 (s,
3H); 13C{1H} NMR (75 MHz, CDCl3) δ 199.6, 158.5, 136.5, 134.7,
133.7, 131.6, 130.5, 129.6, 129.0, 128.2, 127.6, 120.8, 111.6, 55.7,
47.5, 32.7; HRMS (ESI) m/z [M + H]+ calcd for C16H16BrO2
319.0328, found 319.0317.
2-(2-(Bromomethyl)phenyl)-1-(3-methoxyphenyl)ethanone (2c).
The general procedure was followed. Starting with 1c (50.0 mg, 0.21
mmol), TMSBr (33 μL, 37.9 mg, 0.25 mmol) in CH2Cl2 (5 mL), 2c
(54.3 mg, 0.17 mmol, 81%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light
yellow oil: 1H NMR (300 MHz, CDCl3) δ 7.43 (dt, J = 7.6 Hz, J = 1.2
Hz, 1H), 7.32 (dd, J = 2.7 Hz, J = 1.6 Hz, 1H), 7.23−7.11 (m, 2H),
7.16−6.98 (m, 2H), 6.98−6.86 (m, 2H), 4.53 (s, 2H), 4.52 (s, 2H),
3.62 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 197.1, 160.0, 138.0,
136.4, 134.1, 130.9, 130.2, 129.3, 128.7, 127.3, 120.6, 119.5, 112.2,
55.5, 42.6, 32.5; HRMS (ESI) m/z [M + H]+ calcd for C16H16BrO2
319.0328, found 319.0318.
2-(2-(Bromomethyl)phenyl)-1-(4-methoxyphenyl)ethanone (2d).
The general procedure was followed. Starting with 1d (50.0 mg, 0.21
mmol) and TMSBr (33 μL, 37.9 mg, 0.25 mmol) in CH2Cl2 (5 mL),
2d (67.0 mg, 0.21 mmol, 99%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light
yellow oil: 1H NMR (300 MHz, CDCl3) δ 8.13−8.02 (m, 2H), 7.46−
7.35 (m, 1H), 7.32 (dd, J = 6.3 Hz, J = 2.8 Hz, 2H), 7.24−7.14 (m,
1H), 7.05−6.89 (m, 2H), 4.53 (s, 2H), 4.48 (s, 2H), 3.91 (s, 3H);
13C{1H} NMR (75 MHz, CDCl3) δ 195.7, 163.8, 136.4, 134.5, 131.4,
130.8, 130.6, 129.7, 129.2, 127.7, 114.0, 77.5, 77.1, 76.6, 55.6, 42.1,
32.6; HRMS (ESI) m/z [M + H]+ calcd for C16H16BrO2 319.0328,
found 319.0319.
2-(2-(Bromomethyl)phenyl)-1-(3,5-dimethylphenyl)ethanone
(2h). The general procedure was followed. Starting with 1h (50.0 mg,
0.21 mmol) and TMSBr (46 μL, 53.6 mg, 0.35 mmol) in CH2Cl2 (5
mL), 2h (45.3 mg, 0.14 mmol, 68%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.21) as a light yellow
1
oil: H NMR (300 MHz, CDCl3) δ 7.71 (d, J = 1.5 Hz, 2H), 7.49−
7.38 (m, 1H), 7.43−7.21 (m, 3H), 7.25−7.14 (m, 1H), 4.52 (s, 2H),
4.51 (s, 2H), 2.43 (s, 6H); 13C{1H} NMR (75 MHz, CDCl3) δ 197.5,
138.5, 136.8, 136.4, 135.2, 134.4, 131.4, 130.7, 129.2, 127.8, 126.3,
42.6, 32.6, 21.3; HRMS (ESI) m/z [M + H]+ calcd for C17H18BrO
317.0535, found 317.0526.
2-(2-(Bromomethyl)phenyl)-1-(4-fluorophenyl)ethanone (2l).
The general procedure was followed. Starting with 1l (50.0 mg,
0.22 mmol) and TMSBr (35 μL, 40.4 mg, 0.26 mmol) in CH2Cl2 (5
mL), 2l (50.0 mg, 0.16 mmol, 74%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.21) as a light yellow
1
oil. H NMR (300 MHz, CDCl3) δ 8.17−8.06 (m, 2H), 7.50−7.37
(m, 1H), 7.36−7.26 (m, 2H), 7.25−7.13 (m, 3H), 4.51 (s, 2H), 4.50
(s, 2H); 13C{1H} NMR (75 MHz, CDCl3) δ 195.6, 167.7, 136.3,
131.3, 131.2, 131.1, 130.7, 129.3, 127.9, 116.1, 115.8, 42.4, 32.4;
HRMS (ESI) m/z [M + H]+ calcd for C15H13BrFO 307.0128, found
307.0120.
2-(2-(Bromomethyl)phenyl)-1-(4-chlorophenyl)ethanone (2m).
The general procedure was followed. Starting with 1m (50.0 mg,
0.21 mmol) and TMSBr (35 μL, 40.4 mg, 0.26 mmol) in CH2Cl2 (5
mL), 2m (12.9 mg, 0.04 mmol, 19%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light yellow
1
oil. H NMR (300 MHz, CDCl3) δ 8.08−7.97 (m, 2H), 7.54−7.48
(m, 2H), 7.33−7.29 (m, 2H), 7.19−7.07 (m, 2H), 4.50 (s, 2H), 4.49
(s, 2H); 13C{1H} NMR (75 MHz, CDCl3) δ 196.0, 140.0, 136.3,
131.3, 130.7, 129.9, 129.3, 129.1, 128.6, 128.3, 127.9, 42.4, 32.4;
HRMS (ESI) m/z [M + H]+ calcd for C15H13BrClO 322.9838, found
322.9826.
2-(2-(Bromomethyl)phenyl)-1-(4-bromophenyl)ethanone (2n).
The general procedure was followed. Starting with 1n (100.0 mg,
0.34 mmol) and TMSBr (70 μL, 80.8 mg, 0.42 mmol) in CH2Cl2 (8
mL), 2n (8.1 mg, 0.02 mmol, 6%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light yellow
2-(2-(Bromomethyl)phenyl)-1-(o-tolyl)ethanone (2e). The gen-
eral procedure was followed. Starting with 1e (50.0 mg, 0.23 mmol)
and TMSBr (37 μL, 42.8 mg, 0.28 mmol) in CH2Cl2 (5 mL), 2e
(57.8 mg, 0.19 mmol, 83%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light
1
oil. H NMR (300 MHz, CDCl3) δ7.93−7.91 (m, 2H), 7.67−7.61
(m, 2H), 7.43−7.25 (m, 4H), 4.50 (s, 2H), 4.48 (s, 2H); 13C{1H}
NMR (75 MHz, CDCl3) δ 196.2, 136.3, 135.3, 133.7, 133.0, 132.1,
131.3, 130.7, 129.9, 129.3, 127.9, 42.4, 32.3; HRMS (ESI) m/z [M +
H]+ calcd for C15H13Br2O 366.9333, found 366.9328.
1
yellow oil: H NMR (300 MHz, CDCl3) δ 7.87 (dd, J = 7.7 Hz, J =
1.5 Hz, 1H), 7.50−7.40 (m, 2H), 7.40−7.26 (m, 4H), 7.25−7.14 (m,
1H), 4.52 (s, 2H), 4.47 (s, 2H), 2.50 (s, 3H); 13C{1H} NMR (75
MHz, CDCl3) δ 200.7, 138.7, 137.4, 136.4, 134.1, 132.2, 131.7, 131.5,
130.7, 129.2, 128.7, 127.8, 125.9, 77.5, 77.0, 76.6, 45.3, 32.4, 21.4;
HRMS (ESI) m/z [M + H]+ calcd for C16H16BrO 303.0379, found
303.0367.
2-(2-(Bromomethyl)phenyl)-1-(4-hydroxyphenyl)ethanone (2o).
The general procedure was followed. Starting with 1o (50.0 mg, 0.22
mmol) and TMSBr (35 μL, 40.4 mg, 0.26 mmol) in CH2Cl2 (5 mL),
2o (61.2 mg, 0.20 mmol, 90%) was generated after column
chromatography (SiO2, EtOAc/hexanes, 1:1, Rf 0.50) as a light
yellow viscous liquid: 1H NMR (300 MHz, CD3OD) δ 8.06−7.95 (m,
2H), 7.57−7.32 (m, 1H), 7.28−7.25 (m, 2H), 7.21−7.16 (m, 1H),
6.91−6.88 (m, 2H), 4.57 (s, 2H), 4.48 (s, 2H); 13C{1H} NMR (75
MHz, CD3OD) δ 196.9, 162.7, 136.7, 134.9, 131.1, 130.9, 130.3,
128.6, 128.4, 127.1, 115.0, 41.5, 31.6; HRMS (ESI) m/z [M + H]+
calcd for C15H14BrO2 305.0171, found 305.0167.
2-(2-(Bromomethyl)phenyl)-1-(m-tolyl)ethanone (2f). The gen-
eral procedure was followed. Starting with 1f (50.0 mg, 0.23 mmol)
and TMSBr (37 μL, 42.8 mg, 0.28 mmol) in CH2Cl2 (5 mL), 2f (46.0
mg, 0.15 mmol, 66%) was generated after column chromatography
1
(SiO2, EtOAc/hexanes, 1:9, Rf 0.20) as a light yellow oil: H NMR
(300 MHz, CDCl3) δ 7.94−7.88 (m, 2H), 7.50−7.39 (m, 3H), 7.34−
7.29 (m, 2H), 7.24−7.16 (m, 1H), 4.53 (s, 2H), 4.52 (s, 2H), 2.47 (s,
3H); 13C{1H} NMR (75 MHz, CDCl3) δ 197.4, 138.7, 136.7, 136.4,
N-(4-(2-(2-(Bromomethyl)phenyl)acetyl)phenyl)-4-methylbenze-
nesulfonamide (2p). The general procedure was followed. Starting
6911
J. Org. Chem. 2021, 86, 6907−6917